Saint Julien en Genevois, France

Gwenaelle Desforges

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Merck Serono S. a.. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gwenaelle Desforges. Retrieved from https://idiyas.com/inventor/gwenaelle-desforges

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Annemasse, FR (2010)
  • Saint Julien en Genevois, FR (2014 - 2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Gwenaelle Desforges: Pioneering Thiazole Derivatives

Introduction

Gwenaelle Desforges, an esteemed inventor based in Saint Julien en Genevois, France, has made significant contributions to the field of pharmaceutical innovations. With three patents to her name, she is particularly known for her work on thiazole derivatives, which hold the potential to address various serious health conditions.

Latest Patents

Desforges' latest inventions include a series of thiazole derivatives aimed at the treatment and/or prophylaxis of a wide range of diseases. These formulations are designed for conditions such as autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection, and lung injuries. The patents demonstrate the versatility and the potential therapeutic benefits of thiazole derivatives in modern medicine.

Career Highlights

Currently, Gwenaelle Desforges is a key innovator at Merck Serono S.A., where she contributes to groundbreaking research and development efforts. Her expertise in medicinal chemistry and pharmaceutical formulation has positioned her as a valuable asset to the company. Desforges’ focus on creating effective treatments reflects her commitment to enhancing patient care and addressing unmet medical needs.

Collaborations

In her career, Desforges has collaborated with colleagues such as Anna Quattropani and Jerome Dorbais. These partnerships illustrate the collaborative spirit prevalent in research environments, which fosters innovation and accelerates the development of effective therapies. Working alongside talented professionals enables Desforges to enhance the scope and impact of her inventions.

Conclusion

Gwenaelle Desforges stands out as a leading inventor in the pharmaceutical field, with a strong focus on developing thiazole derivatives for various medical applications. Her work at Merck Serono S.A. and her collaborations with esteemed colleagues underscore her commitment to advancing healthcare solutions. As she continues to innovate, her contributions are likely to have a lasting impact on the treatment of complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…